At a glance
ClinicalIndex Comparison RecordN/ACompleted· 437 enrolled
Drug / intervention
Lacticaseibacillus rhamnosus +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Probiotics and Breastmilk Are Associated With a Decreased Risk of Atopic Dermatitis in Very Low Birth Weight Premature Infants
In Brief
An observational study evaluating Lacticaseibacillus rhamnosus and Lactobacillus acidophilus + Bifidobacterium bifidum for Atopic Dermatitis. Completed, enrolled 437 participants.
Detailed Summary
The purpose of this study is assess if the use of probiotic in very low weight could be other benefits a long time, as reduce atopic disease in this children.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionDec 2021
Study CompletionMar 2022
First PostedSep 2023
TodayJul 2026
First PostedSep 13, 2023
Enrollment StartJan 1, 2009
Primary CompletionDec 31, 2021
Study CompletionMar 1, 2022
TodayJul 2, 2026
Enrollment to primary: 13 yearsPosted 2.8 years ago
Interventions
Lacticaseibacillus rhamnosuscombination
Administration Lacticaseibacillus rhamnosus (L. Rhamnosus) ATCC 53103 (109 UFC/day)
Lactobacillus acidophilus + Bifidobacterium bifidumcombination
Administration Lactobacillus acidophilus (L. acidophilus) ATCC 4356 (109 UFC/12 h)+Bifidobacterium bifidum (B. bifidum) ATCC 15696 (109 UFC/12 h)